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The secondary structure of the synthetic signal peptide of cytochrome c oxidase subunit IV (coxIV-25) has been measured by circular dichroism 
spectroscopy in different lipid environments. CoxIV-25 is polymorphic in membranes. It forms an amphiphilic a-helix both in negatively charged 
lipid bilayers (up to 49% helix) and in detergent micclles (up to 42% helix). In associaton with bilayers of the xwitterionic lipid phosphatidylcholine, 
coxIV-25 takes an aperiodic, unidentified structure. CoxIV-25 is also partially a-helical in bilayers of cardiolipin, mitochondrial ipid extracts and 
mixtures of synthetic phosphatidylcholine and phosphatidylglycerol. 
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1. INTRODUCTION 
There is much interest in trying,to understand the 
mechanism of protein translocation across membranes. 
Proteins to be imported into mitochondria are usually 
synthesized as larger precursors with N-terminal signal 
sequences [l]. Most mitochondrial signal sequences are 
removed from the mature protein by specific signal 
peptidases, which reside in the mitochondrial matrix or 
in the inter-membrane space [2]. The information con- 
tained in the mitochondrial signal sequences is 
necessary and, in most cases, sufficient to target pro- 
teins to the mitochondrial membranes, but not to other 
membranes within the eucaryotic cell. Several distinct 
proteinaceous receptors that can recognize mitochon- 
drial protein precursors are known to exist on the outer 
membranes of mitochondria, and different mitochon- 
drial precursors utilize different mitochondrial recep- 
tors on their route into mitochondria [3]. In the past, 
most of the evidence for these receptors came from 
(competitive) binding and antibody blocking ex- 
periments with whole mitochondria. Only recently, a 
candidate for a mitochondrial precursor receptor, 
moml9, could be identified [4]. After binding, the pro- 
tein precursors are translocated into mitochondria in 
the contact sites between the inner and outer mitochon- 
drial membranes [5,6]. A 42 kDa polypeptide, which 
crosslinks to an artificial precursor on its way into 
mitochondria, has recently been found in mitochon- 
drial contact sites [7]. These findings will certainly 
facilitate the search for more components of the 
mitochondrial protein translocation machinery. Never- 
theless, despite these major recent advances, the 
molecular details of the translocation mechanism have 
remained elusive. 
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Apart from binding to receptors and to proteins 
which catalyse the insertion of polypeptides into mem- 
branes and their translocation across mitochondrial 
membranes, mitochondrial signal peptides also exhibit 
high affinities for mitochondrial and synthetic 
phospholipids [8,9]. Practically all mitochondrial 
signal peptides are highly positively charged, and 
negatively charged lipids strongly promote their inser- 
tion into lipid model membranes [9, lo]. Recent binding 
and lateral diffusion experiments of the 25-residue 
signal peptide of cytochrome c oxidase subunit IV 
(coxIV-25) have revealed that this peptide partitions in- 
to the surface region of uncharged bilayers, but 
becomes more deeply inserted into bilayers which con- 
tain negatively charged lipids [lo]. As has been propos- 
ed for a large number of mitochondrial matrix 
targeting peptides [ 111, COXIV-25 adopts an am- 
phiphilic, partially a-helical structure in detergent 
micelles [8]. In the present work, we extend these struc- 
tural studies to phospholipid bilayers of different lipid 
compositions. In particular, we show that this signal 
peptide can assume different secondary structures 
depending on the lipid composition of the host 
membrane. 
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2. MATERIALS AND METHODS 
The sequence of coxIV-25 is: 
Met-Leu-Ser-Leu-Arg-Gln-Ser-Ile-Arg-Phe-Phe-Lys-Pro-Ala-Thr- 
Arg-Thr-Leu-Cys-Ser-Ser-Arg-Tyr-Leu-Leu-CONHr 
This peptide was custom synthesized by Novabiochem AG 
(Switzerland). It eluted as a single peak from a reversed-phase HPLC 
column [lo], and the amino acid composition deviated from the ex- 
pected composition by less than 5%. All synthetic lipids were from 
Avanti Polar Lipids (USA). Cardiolipin of Escherichia coli was from 
Sigma (FRG). 
Mitochondrial lipids were prepared from beef heart mitochondria 
[12] by solvent extraction [13]. Briefly, 100 ml of mitochondrial 
suspension in 0.01 M Tris buffer (pH 7.8) was extracted with 375 ml 
chloroform/methanol (2:l). 180 ml of each, Tris buffer and 
chloroform, were added and the two resulting phases were separated. 
The organic phase was washed with an equal volume of Tris buffer 
and subsequently removed by evaporation under nitrogen. To 
remove the non-polar lipids, the phospholipds were precipitated in a 
SO-fold excess of cold (-20°C) acetone [14] and redissolved in 
chloroform. 19.1 mg of lipid and 12.9 pmol of lipid phosphorus were 
recovered as determined by weighing and by quantitative phosphorus 
determination [15], respectively. Silica gel thin-layer chromatography 
with a mobile phase of chloroform/methanol/acetone/acetic 
acid/water (6 : 2 : 8 : 2 : 1) yielded the expected proportions of 
phosphatidylcholine, phosphatidylethanolamine and cardiolipin (ap- 
prox. 4:4:2) [16,17]. 
Circular dichroism (CD) spectra were recorded as described 
previously [18]. Since coxIV-25 strongly adsorbs to quartz, separate 
samples were prepared at each lipid/peptide ratio, rather than 
titrating a fixed amount of peptide with lipid in the CD cuvette. 
Typically, 5-30 nmol of coxIV-25 in water were mixed with the ap- 
propriate amounts of lipid in chloroform. Methanol was added until 
a clear solution was obtained. The mixtures were dried under a flow 
of nitrogen followed by high vacuum for 2 h. 0.5 ml of aqueous 
0.1 M NaF was added, and the samples were sonicated with a tip 
sonicator for 20-30 min at 10°C under nitrogen. They were used im- 
mediately for CD spectroscopy. After CD measurements, the samples 
were centrifuged at low speed (approx. 2500 x g) to eliminate possible 
large aggregates. The concentrations of peptide and lipid in each sam- 
ple were determined subsequently by quantitative amino acid analysis 
and the organic phosphorus assay [15], respectively. Typically, 
80-90% of the input concentrations of peptide and lipid were 
recovered by this procedure. The CD spectra were corrected for the 
actual peptide concentrations. Normally, peptide concentrations of 
30/M were used at low lipid/peptide ratios and 9 pM at higher 
ratios. 
CD spectra of coxIV-25 in lyso-lecithin were obtained by adding 
the detergent directly to the peptide solution. To improve the 
signal/noise in the spectra with mitochondrial lipids, three spectra of 
individually prepared samples were averaged at each concentration. 
For the calculation of the contents of a-helix, BZZZ = 
30000 deg .cm’/dmol was taken as 100% a-helix [19]. Spectra which 
extended over the full range between 190-250 nm were analysed for 
the contents of the different secondary structures as described 
(20,211. 
3. RESULTS AND DISCUSSION 
Circular dichroism (CD) spectra of COXIV-25 in 
various environments are shown in Fig. 1. The spec- 
trum in 0.1 M NaF and in the absence of any added 
detergent or phospholipid does not show any features 
characteristic for an a-helix which is in agreement with 
previous studies [B]. A fit of this spectrum to a set of 
reference spectra [21] reveals a composition of spectral 
components corresponding to 51% &strand, 15% ran- 
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Fig. 1. Circular dichroism spectra of coxIV-25 in 0.1 M NaF (- - -), 
in association with lyso-lecithin micelles (-), and in association 
with bilayers of POPG (---) and POPC (-----). For each 
spectrum, the respective molar ratios of detergent/peptide or 
lipid/peptide are indicated. 
dom coil and 34% turns and unidentified structures. 
Changing the concentration of COXIV-25 in the range 
between 9-60 PM does not alter the solution spectrum 
of this peptide. When an excess of the detergent lyso- 
lecithin is added, 42% a-helix is induced. 7% is ,&- 
strand and 5 1% are turns and unidentified structures. 
Also shown in Fig. 1 are the CD spectra of this peptide 
in association with small unilamellar vesicles of 
1-palmitoyl-2-oleoyl-phosphatidylglycerol (POPG) and 
of 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC). 
The spectrum in POPG is qualitatively very similar to 
that in lyso-lecithin, although the absolute mean 
residue molar ellipticities are somewhat larger. The 
content of a-hehx in this spectrum is determined to be 
49% from the mean residue molar ellipticity at 222 nm. 
A totally different spectrum is observed when 
COXIV-25 is associated with bilayers of POPC (Fig. 1). 
No characteristic features of an a-helical structure are 
evident. The spectrum is also distinct from that record- 
ed in solution. Unfortunately, the far UV part of this 
spectrum could not be measured because of light scat- 
tering of the lightly turbid solution. Due to the lack of 
spectral information between 190 and 204 nm, this 
spectrum could not be fitted unambiguously to the 
reference spectra. Nevertheless, the spectrum above 
204 nm closely resembles reference spectra for 
unordered structures [20,22]. Maxima around 220 nm 
are common in polypeptide structures which are not ex- 
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Fig. 2. Comparison of the ability of POPG and cardiolipin to induce an a-helical structure in COXIV-25. Circular dichroism spectra of coxIV-25 
in bilayers of the two phospholipids are shown at various lipid/peptide ratios as indicated. 
tensively hydrogen-bonded such as, for example, 
polylysine at pH 7, polyproline I and collagen [23,24]. 
Thus, COXIV-25 in association with POPC takes an 
unordered, non-a-helical and extended structure which 
is different from its solution structure and which can- 
not be precisely determined from the present CD data. 
With a partition constant of 3900 M-* [lo], it can be 
estimated that 95% of all COXIV-25 is bound to POPC 
under the conditions of the CD experiment of Fig. 1. 
Furthermore, our lateral diffusion experiments [IO] 
have suggested that COXIV-25 partitions into the 
headgroup region of POPC bilayers without 
penetrating much into the hydrophobic interior of the 
bilayer. Therefore, the spectrum in POPC must repre- 
sent a conformation of COXIV-25 in the headgroup 
region of this lipid bilayer. A deeper insertion of 
coxIV-25, to the point of being partially in the 
hydrophobic region of negatively charged bilayers, has 
been previously deduced from lateral diffusion ex- 
periments in POPG [lo]. The present results now sug- 
gest that only in this deeper state of association does the 
membrane provide enough hydrophobic surface to in- 
duce a substantial amount of a-helix in this peptide. 
tide (L/P) ratios of 33: 1 or more. An almost 
featureless CD spectrum is observed at L/P = 5, where 
nearly all charges on the peptide are compensated by a 
lipid charge. The low intensity of this spectrum is not 
due tp a precipitation of the complexes, because most 
of the peptide and lipid is recovered after low speed 
centrifugtion of the clear solution. All spectra with L/P 
2 5 (L/P = 0 excluded) intersect at an isodichroic point 
near 203 nm. This indicates (i) that there is a two-state 
equilibrium between the L/P = 5 and the L/P = 33 
structures in this concentration range and (ii) that the 
solution structure (L/P = 0) does not take part in this 
equilibrium. 
The spectra recorded in the presence of cardiolipin 
are similar to those recorded with POPG although 
there are some differences. The minimum at 
206-208 nm is always more pronounced than that at 
222 nm. An isodichroic point around 200 nm is again 
found and the spectral intensities increase in about the 
same relative proportions as in POPG with increasing 
L/P. However, although cardiolipin resembles struc- 
turally a dimer of POPG, it does not appear to be twice 
as potent as POPG in inducing the a-helix in COXIV-25. 
Cardiolipin is the major negatively charged lipid CD spectra with increasing ratios of 
species in the outer and inner membranes of mitochon- POPC :coxIV-25 are shown in Fig. 3. In this case, no 
dria [16,17]. Being the biosynthetic precursor of car- isodichroic point is observed. In fact, the spectra 
diolipin, negatively charged phosphatidylglycerol is change gradually from the predominantly fl- 
also present in mitochondrial membranes. The syn- strand/turn/random structure (L/P = 0), to a structure 
thetic phosphatidylglycerol POPG which resembles which appears to have some helical components at low 
structurally half a cardiolipin molecule has been L/P ratios (8 and 41) and then to the predominantly 
previously used as a model lipid in binding and lateral unordered structure at high L/P ratios (562 and 656). 
diffusion studies with coxIV-25 [9,10]. Fig. 2 shows a It is possible that COXIV-25 and POPC associate in 
comparison of the ability of POPG and cardiolipin to micelle-like structures at low L/P and that POPC 
induce an cr-helical structure in COXIV-25. With POPG, makes more hydrophobic surface available to coxIV-25 
the maximal amount of a-helix is induced at lipid/pep- in these complexes than in lipid bilayers. This would ex- 
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Fig. 3. A non+-helical, aperiodic structure is induced in coxIV-25 
when it associates with bilayers of POPC. Circular dichroism spectra 
of coxIV-25 in association with POPC are shown at various 
lipid/peptide ratios as indicated. 
plain the transient increase of a-helix of COXIV-25 in 
POPC and is in line with the high amount of a-helix 
found in micelles of lyso-lecithin (Fig. l), which has the 
same headgroup structure as POPC. 
Fig. 4 shows the structure of COXIV-25 in the 
phospholipids that were extracted from mitochondria. 
Apparently, the mitochondrial phospholipids, which 
contain about 20-30 mol% of negatively charged 
phospholipids (20-25 mol% cardiolipin) [ 16,171, can 
induce a substantial amount of cr-helix (41% at L/P = 
200) in this signal peptide. It is also evident from Fig. 4 
that synthetic lipid mixtures of POPWPOPG (7 : 3) (or 
POPC/CL (7 : 3), data not shown) can mimic the effect 
of the natural lipid mixture quite well. Previously, we 
found that the lateral diffusion coefficient of COXIV-25 
is reduced in bilayers of the synthetic lipid mixture of 
POPWPOPG (4: 1) by about the same amount as in 
bilayers of pure POPG [lo]. The present structural and 
the earlier dynamic investigations taken together show 
that 20-30 mol% of negatively charged lipids are suffi- 
cient to induce the amphiphilic helix in COXIV-25 and to 
pull it deeper into the membrane allowing for elec- 
trostatic and hydrophobic interactions of the signal 
peptide with the membrane lipids to occur. 
Is the observed conformational polymorphism of 
coxIV-25 a general property of signal peptides in mem- 
branes and is it required for their function? Answers to 
these questions cannot yet be given on the basis of the 
presently available experimental data. Although it has 
been detected here for the first time in an amphiphilic 
I I 
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Fig. 4. The a-helix of coxIV-25 is also induced in bilayers of 
mitochondrial phospholipids and in synthetic bilayers composed of 
POPC and POPG. Circular dichroism spectra of coxIV-25 in 
mitochondrial phospholipids at three lipidjpeptide ratios (broken 
lines) and one spectrum in POPC/POPG (7 : 3; L/P = 100; solid line) 
are shown. 
signal sequence, there is evidence from other studies in- 
dicating that conformational polymorphism might be a 
common property of most signal sequences. For in- 
stance, there is the precedent of the ‘hydrophobic’ 
signal peptide which targets the 1umB gene product 
across the cytoplasmic membrane to the outer mem- 
brane of E. coli. This peptide has been found to adopt 
either LY- or &structure, depending on the lateral 
pressure at which the phospholipid bilayers have been 
prepared on the solid substrate [25]. Circumstantial 
evidence for conformational flexibility comes also from 
(i) an artificial signal sequence which was designed for 
maximal helical amphiphilicity but which forms an am- 
phiphilic &strand in SDS micelles [26]; (ii) the or- 
nithine carbamyl-transferase signal sequence in which 
all 27 residues will form an a-helix in membranes 
whereas the central 12 residues which from 
hydrophobic moment prediction [27] should fold into a 
highly amphiphilic a-helix actually forms a &strand in 
membranes [28]; and (iii) the mannitol PTS permease 
signal sequence where also the 23 most N-terminal 
residues (rather than the terminal 15) are required for 
the induction of an amphiphilic helix in SDS or POPG 
([18]; Tamm, L., Bartoldus, I., Tomich, J. and Saier 
Jr, M., unpublished results). Thus, it appears that 
many signal peptides can assume several structures in 
lipid bilayers and that parameters uch as lipid charge, 
lipid pressure, lipid shape, and, perhaps, insertion pro- 
32 
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teins can control the conformation of these sequences 
in membranes. 
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